Horizon Therapeutics Public Ltd Co

Parallel Advisors, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

5/20/2024

Shares

454

Value ($000)

53

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	5/20/2024	53	0.0%	454	9/30/2023
2023 Q2	5/20/2024	47	0.0%	457	6/30/2023
2023 Q1	5/20/2024	50	0.0%	457	3/31/2023
2022 Q4	2/6/2023	52	0.0%	457	12/31/2022
2022 Q3	11/10/2022	29	0.0%	461	9/30/2022
2022 Q2	8/1/2022	23	0.0%	294	6/30/2022
2022 Q1	4/28/2022	43	0.0%	408	3/31/2022
2021 Q4	1/20/2022	27	0.0%	246	12/31/2021
2021 Q3	11/2/2021	36	0.0%	329	9/30/2021
2021 Q2	8/6/2021	24	0.0%	254	6/30/2021
2021 Q1	4/23/2021	21	0.0%	228	3/31/2021
2020 Q4	2/2/2021	9	0.0%	117	12/31/2020
2020 Q3	10/27/2020	8	0.0%	97	9/30/2020
2020 Q2	7/16/2020	3	0.0%	57	6/30/2020
2020 Q1	4/27/2020	1	0.0%	62	3/31/2020
2019 Q4	1/30/2020	2	0.0%	57	12/31/2019